Regular paper
The impact of the PCR plateau phase on quantitative PCR

https://doi.org/10.1016/0167-4781(94)90076-0Get rights and content

Abstract

The quantitative use of the polymerase chain reaction (PCR) is often compromised by the variability of the amplification. The most useful system for quantitation by PCR involves the use of controls which are almost identical to the target and which can be amplified using the same primers as the sequences of interest. In this paper, we use a model system consisting of differently sized targets amplifiable with varying primers to demonstrate the effects of the plateau phase of PCR on quantitation by PCR. This model confirms two commonly observed results: (i) when varying amounts of a single target are amplified, a constant maximum level of product is obtained and (ii) coamplification of different concentrations of different targets results in retention of the initial proportions. The inherent contradiction in these results is examined by replacement of the key elements of the reaction including enzyme, dNTPs or primers, none of which have an effect on the plateau. Pyrophosphate is found to exert no inhibitory effect on the reaction, nor does the exonuclease action of the enzyme cause the plateau. Levels of amplification attained during amplification are both theoretically and empirically defined as being insufficient to lead to the plateau due to competition between self-annealing of product DNAs and primer binding. We conclude that, pending further biochemical enquiry into the enzyme(s) used in the PCR, none of reasons conventionally proposed for the plateau phase of the PCR are sufficient to explain the phenomenon. This being so, we define the plateau as being a feature of the reaction as a whole and, since the onset of this phase is simultaneous for all amplicons, quantitation using the internal control system need not require exponential amplification. This therefore greatly simplifies the quantitative application of PCR.

References (40)

  • A. Akane et al.

    For. Sci. Int.

    (1991)
  • S.R. Carding et al.

    J. Immunol. Methods

    (1992)
  • R.J. Wiesner et al.

    Biochem. Biophys. Res. Commun.

    (1992)
  • J. Nedelman et al.

    Bull. Math. Biol.

    (1992)
  • J.G. Wetmur et al.

    J. Mol. Biol.

    (1968)
  • R.J. Britten et al.

    Methods Enzymol.

    (1974)
  • F.W. Alt et al.

    J. Biol. Chem.

    (1978)
  • S. Santagati et al.

    Biochem. Pharmacol.

    (1993)
  • S. Love et al.

    Neuropathol. Appl. Neurobiol.

    (1992)
  • P.A. Wright et al.

    J. Pathol.

    (1990)
  • K.N. Kasturi et al.

    Nucleic Acids Res.

    (1991)
  • J.D. Hayden et al.

    Rev. Med. Microbiol.

    (1991)
  • T.Y. Nakagawa et al.

    Eur. J. Immunol.

    (1991)
  • M.A. Innis et al.

    PCR Protocols - A Guide to Methods and Applications

    (1990)
  • A.D. Sardelli

    Amplifcations

    (1993)
  • W. Bloch

    Biochemistry

    (1991)
  • M.J. McPherson et al.
  • N. Arnheim et al.

    Annu. Rev. Biochem.

    (1992)
  • A. Belyavsky et al.

    Nucleic Acids Res.

    (1989)
  • Ü Linz et al.

    J. Clin. Chem. Clin. Biochem.

    (1990)
  • Cited by (80)

    • Challenging the proposed causes of the PCR plateau phase

      2019, Biomolecular Detection and Quantification
      Citation Excerpt :

      Studies aiming at investigating reagent depletion as a limiting factor of PCR product formation report conflicting results. The addition of nucleotides or primers after reaching the plateau phase has been shown not to re-start amplification [6,7], suggesting that neither of these are the limiting factor. On the contrary, others describe that initially increased primer concentrations [8] and addition of primers at the linear phase [2] led to increased product formation at late cycles.

    • Tools and resources for analyzing gene expression changes in glaucomatous neurodegeneration

      2015, Experimental Eye Research
      Citation Excerpt :

      The discovery of Taq polymerase and its application to cycling amplification (Mullis and Faloona, 1987; Saiki et al., 1988) dramatically overcame the need for a lot of input sample. End-stage Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) was not a reasonable technology for quantification, however, because of the plateau effect that was achieved in a typical reaction, regardless of the amount of input target template (Morrison and Gannon, 1994). To overcome this, “real-time” technology was developed, which allows direct measurement of the concentration of newly synthesized DNA at the completion of every extension cycle.

    View all citing articles on Scopus
    1

    Present address: Institute for Molecular Pathology, Dr. BohrGasse 7, Vienna, Austria.

    View full text